HomeBUSINESS
BUSINESS

Hisamitsu Launches US PII Study for Analgesic Transdermal Patch
(Sep.26.2017)

Japanese patch drug powerhouse Hisamitsu Pharmaceutical said on September 25 that it has kicked off a PII clinical study in the US for the analgesic transdermal patch HP-5000 (diclofenac) ...
(LOG IN FOR FULL STORY)

News Calendar